Medical Science Liaison (MSL), Rheumatology (Primary focus: telitacicept for Sjögren’s Disease)
Location: Southern California/Southwest | Travel: ~50–70% | Reports to: National Executive Director
Key Responsibilities
- Build and maintain expertise in the rheumatology pipeline, disease biology, and evolving treatment landscape.
- Serve as a trusted scientific resource for internal teams and external stakeholders.
- Partner with Medical Affairs, Clinical Development/Clinical Operations, and Commercial to align strategies with scientific and patient community needs.
- Identify opportunities for scientific communication and evidence generation (publications, education initiatives, advisory programs).
- Participate in rheumatology meetings and congresses; gather and share insights internally.
- Establish relationships with KOLs, investigators, and rheumatology clinical specialists; facilitate transparent, non-promotional scientific exchange.
- Engage investigators and trial sites to support enrollment, protocol understanding, and research collaboration.
- Support evidence generation through IIS and outcomes research collaborations.
- Provide timely, compliant responses to medical/scientific inquiries.
- Support advisory boards, educational initiatives, and training programs.
Skills & Competencies
- Strong scientific acumen; translate complex data for expert discussions.
- Relationship-building; comfort engaging with rheumatologists/researchers/healthcare providers.
- Understanding of clinical trial operations and site engagement.
- Familiarity with the U.S. healthcare environment (academic and community rheumatology).
- Collaborative across functions; independent field work.
- Strong communication/presentation/interpersonal skills; strong organization and prioritization.
Preferred Qualifications
- Advanced degree (PharmD, PhD, MD/DO).
- 3+ years MSL or equivalent field-based medical affairs experience (biotech/pharma).
- Prior MSL experience in Sjögren’s Disease.
- Knowledge of medical and regulatory standards for HCP interactions.